October 7, 2020. Chinese Academy of Medical Sciences pithor te Institute of Medical Biology para Chinese experimental coronavirus vaccine bonai thaka toh early stage clinical trial samay safe ase koikena thikai ase koikena, researchers para janai thishe. Phase 1 trial thaka samay 191 healthy manuh khan 18 umer para 59 umer logot vaccine toh experimental thishe, aro eku beya reactions thika nai, koikena Tuesday din researchers para medRxiv preprint server te posted korishe. Trial manuh (participants) khan logot vaccine deya beche olop reactions thaka toh pain, slight fatigue aro redness, itching aro swelling khan hoishe. Candidate khan logot immune response be paishe koishe. “data paa para toh vaccine nemite safety aro immunogenicity support korishe, aro etu para ahibo din studies koribo nemite be tangor besas ase” koikena paper para koishe. China para hundreds of thousands kam kora manuh aro dosura groups risk te thaka khan ke vaccine toh marishe, hoilebi eta dak clinical trials kori thaka toh pura kotom nahoin ase, etu nemite experts khan safety neimite tangor bapana kori ase. Etai dak China te charta(4) experimental vaccines toh clinical trials final stage te ase koishe.
China laga Experimental COVID-19 Vaccine safe ase









Add Comment